1. Home
  2. CBT vs TMDX Comparison

CBT vs TMDX Comparison

Compare CBT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBT
  • TMDX
  • Stock Information
  • Founded
  • CBT 2019
  • TMDX 1998
  • Country
  • CBT United States
  • TMDX United States
  • Employees
  • CBT N/A
  • TMDX N/A
  • Industry
  • CBT Major Chemicals
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CBT Industrials
  • TMDX Health Care
  • Exchange
  • CBT Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • CBT 4.0B
  • TMDX 3.9B
  • IPO Year
  • CBT N/A
  • TMDX 2019
  • Fundamental
  • Price
  • CBT $61.37
  • TMDX $114.30
  • Analyst Decision
  • CBT Hold
  • TMDX Buy
  • Analyst Count
  • CBT 3
  • TMDX 11
  • Target Price
  • CBT $79.33
  • TMDX $130.73
  • AVG Volume (30 Days)
  • CBT 488.1K
  • TMDX 1.0M
  • Earning Date
  • CBT 11-03-2025
  • TMDX 10-29-2025
  • Dividend Yield
  • CBT 2.92%
  • TMDX N/A
  • EPS Growth
  • CBT N/A
  • TMDX 170.70
  • EPS
  • CBT 6.02
  • TMDX 2.54
  • Revenue
  • CBT $3,713,000,000.00
  • TMDX $566,354,000.00
  • Revenue This Year
  • CBT $6.09
  • TMDX $38.84
  • Revenue Next Year
  • CBT $3.05
  • TMDX $20.46
  • P/E Ratio
  • CBT $10.23
  • TMDX $45.35
  • Revenue Growth
  • CBT N/A
  • TMDX 41.20
  • 52 Week Low
  • CBT $58.99
  • TMDX $55.00
  • 52 Week High
  • CBT $115.16
  • TMDX $145.50
  • Technical
  • Relative Strength Index (RSI)
  • CBT 29.02
  • TMDX 40.85
  • Support Level
  • CBT $60.03
  • TMDX $115.21
  • Resistance Level
  • CBT $62.57
  • TMDX $125.57
  • Average True Range (ATR)
  • CBT 1.94
  • TMDX 7.65
  • MACD
  • CBT -0.10
  • TMDX -1.72
  • Stochastic Oscillator
  • CBT 19.90
  • TMDX 12.41

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: